BIOSIG TECHNOLOGIES INC (BSGM)
US09073N3008 - Common Stock
Overall BSGM gets a fundamental rating of 1 out of 10. We evaluated BSGM against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of BSGM have multiple concerns. BSGM is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BSGM had negative earnings in the past year.
In the past year BSGM has reported a negative cash flow from operations.
BSGM had negative earnings in each of the past 5 years.
BSGM had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -1589.24%, BSGM is not doing good in the industry: 98.93% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1589.24% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-828.31%
ROA(5y)-579.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BSGM's Gross Margin of 66.67% is fine compared to the rest of the industry. BSGM outperforms 71.12% of its industry peers.
The Profit Margin and Operating Margin are not available for BSGM so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.67% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
BSGM does not have a ROIC to compare to the WACC, probably because it is not profitable.
BSGM has more shares outstanding than it did 1 year ago.
BSGM has more shares outstanding than it did 5 years ago.
There is no outstanding debt for BSGM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
Based on the Altman-Z score of -270.35, we must say that BSGM is in the distress zone and has some risk of bankruptcy.
BSGM has a Altman-Z score of -270.35. This is amonst the worse of the industry: BSGM underperforms 97.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -270.35 |
ROIC/WACCN/A
WACC9.21%
2.3 Liquidity
A Current Ratio of 0.14 indicates that BSGM may have some problems paying its short term obligations.
BSGM has a worse Current ratio (0.14) than 96.79% of its industry peers.
BSGM has a Quick Ratio of 0.14. This is a bad value and indicates that BSGM is not financially healthy enough and could expect problems in meeting its short term obligations.
BSGM has a Quick ratio of 0.14. This is amonst the worse of the industry: BSGM underperforms 96.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.14 | ||
| Quick Ratio | 0.14 |
3. Growth
3.1 Past
BSGM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.81%, which is quite impressive.
Looking at the last year, BSGM shows a very negative growth in Revenue. The Revenue has decreased by -93.71% in the last year.
EPS 1Y (TTM)66.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)-93.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
BSGM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.77% yearly.
The Revenue is expected to grow by 123.61% on average over the next years. This is a very strong growth
EPS Next Y75.83%
EPS Next 2Y34.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y123.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
BSGM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BSGM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BSGM's earnings are expected to grow with 34.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.77%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BSGM does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIOSIG TECHNOLOGIES INC
NASDAQ:BSGM (12/20/2024, 8:00:01 PM)
After market: 1.3 -0.04 (-2.99%)1.34
+0.04 (+3.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.01%
Inst Owner Change2826.76%
Ins Owners26.87%
Ins Owner Change17.11%
Market Cap23.09M
Analysts82.86
Price Target2.55 (90.3%)
Short Float %1.41%
Short Ratio0.42
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-41.24%
Min EPS beat(2)-60.78%
Max EPS beat(2)-21.7%
EPS beat(4)1
Avg EPS beat(4)-25.89%
Min EPS beat(4)-62.27%
Max EPS beat(4)41.18%
EPS beat(8)2
Avg EPS beat(8)-14%
EPS beat(12)4
Avg EPS beat(12)-9.9%
EPS beat(16)6
Avg EPS beat(16)-10.81%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-58.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-63.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 855.12 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.6
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-0.76
FCFYN/A
OCF(TTM)-0.75
OCFYN/A
SpS0
BVpS-0.24
TBVpS-0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1589.24% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.67% | ||
| FCFM | N/A |
ROA(3y)-828.31%
ROA(5y)-579.31%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.02
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 39.72% | ||
| Cap/Sales | 522.22% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.14 | ||
| Quick Ratio | 0.14 | ||
| Altman-Z | -270.35 |
F-Score1
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)127.53%
Cap/Depr(5y)201.17%
Cap/Sales(3y)404.99%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y75.83%
EPS Next 2Y34.77%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-93.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year-100%
Revenue Next 2Y123.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year408.27%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.18%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.8%
OCF growth 3YN/A
OCF growth 5YN/A